Mumbai, Oct. 21 -- Net sales jumped 75.94% year-on-year (YoY) to Rs 217.32 crore in the quarter ended 30 September 2026.

Profit before tax (PBT) soared 111.70% YoY to Rs 28.94 crore in Q2 FY27.

EBITDA surged 83% YoY to approximately Rs 40.7 crore in Q2 FY27, compared with Rs 22.2 crore in Q2 FY26. EBITDA margin improved to 19% from 18% in the corresponding quarter last year.

In terms of revenue contribution, Structure Directing Agents (SDA) accounted for 45% of total revenue, followed by Pharma & Agrochemical Intermediates (PASC) at 30%, Phase Transfer Catalysts (PTC) at 21%, Electrolyte Salts (ESS) at 3% and other products at 1%.

For the first half of FY27, the company reported a 125.93% rise in consolidated net profit to Rs 37.4 cro...